SCHEMBL28065615

SCHEMBL28065615

COc1cc(N2CCC(N(C)C)CC2)ccc1N.Cc1ccnc(N)n1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.42
PLK1 P53350 4/20 0.42
ALK Q9UM73 6/20 0.41
SUV39H2 Q9H5I1 1/20 0.41
AURKA O14965 1/20 0.41
INSR P06213 1/20 0.41
IGF1R P08069 1/20 0.41
ROS1 P08922 1/20 0.41
EML4 Q9HC35 1/20 0.41
JAK2 O60674 1/20 0.39
CDK1 P06493 2/20 0.39
CDK2 P24941 1/20 0.39
ACVR1 Q04771 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL310055 0.85 SUV39H2 (0.45) EGFRPLK1ALKSUV39H2AURKA
SCHEMBL29661369 0.85 SUV39H2 (0.45) EGFRPLK1ALKSUV39H2AURKA
Hydrochloric Acid SCHEMBL29367159 0.84 SUV39H2 (0.44) EGFRPLK1ALKSUV39H2AURKA
SCHEMBL10206636 0.79 ALK (0.44) EGFRPLK1ALKSUV39H2AURKA
SCHEMBL14240636 0.78 NTSR1 (0.47) ALKSUV39H2INSRIGF1R
SCHEMBL520746 0.78 NTSR1 (0.47) ALKSUV39H2INSRIGF1R
SCHEMBL24603026 0.76 SUV39H2 (0.45) EGFRPLK1ALKSUV39H2AURKA
SCHEMBL1783282 0.75 MAPT (0.45) EGFRPLK1ALKSUV39H2AURKA
SCHEMBL3132203 0.75 ACVR1 (0.45) EGFRALKSUV39H2AURKAINSR
SCHEMBL10206172 0.74 ACVR1 (0.43) SUV39H2ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105683168-B Fragrant amino pyrimidines and its application and pharmaceutical composition prepared therefrom and Pharmaceutical composition 上海海雁医药科技有限公司 2017-12-08 CN disclosed
CN-105683168-A Arylamino pyramidine compound and application thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefrom 上海海雁医药科技有限公司 2016-06-15 CN disclosed